Henry J. Fuchs - 01 Dec 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
President, Worldwide R&D
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
01 Dec 2023
Net transactions value
+$21,200
Form type
4
Filing time
05 Dec 2023, 16:56:58 UTC
Previous filing
11 Aug 2023
Next filing
29 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $21,200 +317 +0.18% $66.88 176,504 28 Apr 2023 Direct F1
transaction BMRN Common Stock Award $0 +17,750 +10% $0.000000 194,254 01 Dec 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares acquired by the reporting person on April 28, 2023, pursuant to the issuer's Employee Stock Purchase Plan.
F2 Restricted stock units granted on December 1, 2023. Price not applicable.